Cargando…

Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?

SIMPLE SUMMARY: Since the discovery of the role of the three driver mutations (JAK2, CALR and MPL) and the constitutive activation of the JAK/STAT pathway in myeloproliferative neoplasms, the disease has been wrongly considered to be molecularly elucidated, and efforts have mainly focused on the imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales, María Luz, Ferrer-Marín, Francisca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954305/ https://www.ncbi.nlm.nih.gov/pubmed/36831689 http://dx.doi.org/10.3390/cancers15041348

Ejemplares similares

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
por: Ferrer-Marín, Francisca, et al.
Publicado: (2021)

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Editorial: Deepening our understanding of the etiology of gaming disorder and gambling disorder
por: Long, Jiang, et al.
Publicado: (2023)

Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
por: McKinnell, Zoe, et al.
Publicado: (2022)

Cancer Stem Cells: What Do We Know about Them?
por: Skvortsova, Ira
Publicado: (2021)

Deepening Our Roots and Growing Wings
por: Zhang, Deqing, et al.
Publicado: (2021)

Now, we all know about the Osborne-Cotterill lesions, but we still don’t know how to treat them
por: Lee, Jong Heon, et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2020)

The Myeloproliferative Neoplasm Landscape: A Patient’s Eye View
por: Petruk, Cheryl, et al.
Publicado: (2020)

Commentary: What we should know about our learners
por: Groth, Shawn S., et al.
Publicado: (2020)

The investigators reflect: what we have learned from the Deepening our Understanding of Quality Improvement in Europe (DUQuE) study
por: Groene, O., et al.
Publicado: (2014)

What are interesterified fats and should we be worried about them in our diet?
por: Mills, C. E., et al.
Publicado: (2017)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
por: Gerke, Margo B., et al.
Publicado: (2023)

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
por: Easwar, Arti, et al.
Publicado: (2021)

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
por: Morsia, Erika, et al.
Publicado: (2022)

The Genomic Landscape in Philadelphia-Negative Myeloproliferative Neoplasm Patients with Second Cancers
por: Hsu, Chia-Chen, et al.
Publicado: (2022)

Are we failing our students….by passing them?
por: Dani, Nitin
Publicado: (2018)

What we know but do not understand about nidovirus helicases
por: Lehmann, Kathleen C., et al.
Publicado: (2015)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

Regenerating Myofibers after an Acute Muscle Injury: What Do We Really Know about Them?
por: Pizza, Francis X., et al.
Publicado: (2023)

What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract
por: Fernández-Reina, Alberto, et al.
Publicado: (2018)

How Well Did We Know About Our Communication? “Origins of Human Communication”
por: Son, Jung-Woo
Publicado: (2023)

Enteric Neuromics: How High-Throughput “Omics” Deepens Our Understanding of Enteric Nervous System Genetic Architecture
por: Dharshika, Christine, et al.
Publicado: (2022)

Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms
por: Bochicchio, Maria Teresa, et al.
Publicado: (2022)

Transcriptomic and Metabolomic Approaches Deepen Our Knowledge of Plant–Endophyte Interactions
por: Chen, Xue-liang, et al.
Publicado: (2022)

Allergies to Titanium Dental Implants: What Do We Really Know about Them? A Scoping Review
por: Comino-Garayoa, Rubén, et al.
Publicado: (2020)

Deactylase inhibition in myeloproliferative neoplasms
por: Mithraprabhu, Sridurga, et al.
Publicado: (2010)

Guidelines for the management of myeloproliferative neoplasms
por: Choi, Chul Won, et al.
Publicado: (2015)

The Hematopoietic Niche in Myeloproliferative Neoplasms
por: Schmitt-Graeff, Annette H., et al.
Publicado: (2015)

Calreticulin Mutations in Myeloproliferative Neoplasms
por: Lavi, Noa
Publicado: (2014)

Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3b493csu9mcjdqclmk1v1089et